Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker Study.

Ulagamadesan VenkatesanSibylle HessBrian ClaggettKenneth DicksteinLars KoberAldo P MaggioniJohn Joseph Valentine McMurrayJeffrey L ProbstfieldMatthew C RiddleJean-Claude TardifMarc A Pfeffer

Published in: Diabetes care (2022)

NT-proBNP and other proteins independently predict cardiovascular outcomes in people with type 2 diabetes following acute coronary syndrome. Adding other biomarkers only marginally increased NT-proBNP's prognostic value.

Keyphrases

acute coronary syndrome
percutaneous coronary intervention
antiplatelet therapy
small molecule
protein protein
amino acid
atrial fibrillation
coronary artery disease